Nav: Home

Cedars-Sinai receives $10 million for pioneering studies of debilitating digestive tract disease

December 05, 2016

LOS ANGELES (Dec. 5, 2016) - Cedars-Sinai investigators in gastroenterology have been awarded $10 million by the National Institutes of Health to conclude a groundbreaking, decades-long investigation of the genetic and immunological causes of inflammatory bowel disease (IBD).

"This is the longest IBD study of its kind funded by the NIH and the first to explore the genetic makeup of the disease," said Stephan R. Targan, MD, director of the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute at Cedars-Sinai.

"Since 1992, we've taken an integrative approach - bringing several areas of science together - to demonstrate that this challenging disease is in fact comprised of several forms of the disease, each with a different biology," added Targan, the study's principal investigator.

The interdisciplinary research has shown that inflammatory bowel disease is actually a spectrum of chronic illnesses that cause painful inflammation of the intestines. Crohn's disease and ulcerative colitis are the commonly recognized forms of IBD. But the disease can manifest in a variety of ways that lead to the destruction of the digestive tract, causing chronic physical, psychological and emotional problems.

A more precise diagnosis enables physicians to prescribe the most effective treatments available, tailored to each patient's particular biological makeup.

"Using molecular signatures to identify subgroups of IBD - and taking into account a patient's disease severity and response to treatment - is all about getting the right therapy to the right patient at the right time," said Dermot McGovern, MD, PhD, professor of Medicine and Biomedical Sciences and director of Cedars-Sinai Precision Health.

"Work from this project is making very significant contributions to helping patients around the world. These approaches to diagnosis and treatment should be available to all sections of society, and we have been working hard to achieve those goals," said McGovern, who served as the principal investigator for the first project in the ongoing study.

David Underhill, PhD, professor of Biomedical Sciences, and the Janis and William Wetsman Family Chair in Inflammatory Bowel Disease at Cedars-Sinai, also has contributed to the study by investigating how IBD might be affected by the relationship between the immune system and the fungal communities in the digestive tract.

"Examining IBD through all these various genetic and biological lenses is pointing the way to novel therapeutic approaches that could finally bring relief and healing to many patients," Targan said.
-end-


Cedars-Sinai Medical Center

Related Inflammatory Bowel Disease Articles:

Cell therapy designed to treat inflammatory bowel disease
The UPV/EHU's NanoBioCel research group has for many years been developing systems enabling cells to be used as drugs.
Team develops wearable sensor to help people with inflammatory bowel disease
University of Texas at Dallas researchers have designed a wearable device that monitors sweat for biomarkers that could signal flare-ups of inflammatory bowel disease (IBD).
Antibiotics associated with increased risk of inflammatory bowel disease
Antibiotics use, particularly antibiotics with greater spectrum of microbial coverage, may be associated with an increased risk of new-onset inflammatory bowel disease (IBD) and its subtypes ulcerative colitis and Crohn's disease.
Yes, inflammatory bowel disease and celiac disease are linked
A systematic review and meta-analysis that has determined there is a nine-fold increased risk of having IBD for patients with a previous diagnosis of celiac disease.
The effects of inflammatory bowel disease on pregnancy
Inflammatory bowel disease (IBD) -- including Crohn's disease and ulcerative colitis -- often affects women of childbearing age.
5 major advances in inflammatory bowel disease (IBD) treatment
Summary of five impactful studies to be presented at the Crohn's & Colitis Congress, a partnership of the Crohn's & Colitis Foundation and the American Gastroenterological Association (AGA).
Researchers identify a possible cause and treatment for inflammatory bowel disease
In a study published online in PNAS on Jan. 20, 2020, Prof.
Does inflammatory bowel disease carry certain risks during pregnancy?
Pregnant women with inflammatory bowel disease (IBD) are more likely to undergo delivery by Caesarean section and face certain risks during pregnancy, according to an analysis published in Alimentary Pharmacology & Therapeutics.
Inhibiting a protease could improve the treatment of inflammatory bowel disease
Scientists at the CNIC and CSIC have identified a function of a protease that could be the future target of drugs to treat inflammatory bowel disease.
Inflammatory bowel disease appears to impact risk of Parkinson's disease
Amsterdam, NL, November 14, 2019 - Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years.
More Inflammatory Bowel Disease News and Inflammatory Bowel Disease Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.